2002
DOI: 10.1016/s0014-2999(02)02251-3
|View full text |Cite
|
Sign up to set email alerts
|

Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

12
67
0

Year Published

2004
2004
2018
2018

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 93 publications
(80 citation statements)
references
References 19 publications
12
67
0
Order By: Relevance
“…Accordingly, nephrotoxicity by cisplatin is characterized by renal electrolyte disturbances and by acute fall in glomerular filtration rate (GFR) [27,28]. Cisplatin teatment was found to cause diffuse tubular necrosis and desquamation and parenchyma degeneration in the cortex [29]. In the current study, turbular damage was similar to control kidney of a previous reportd study.…”
Section: Effect Of Fbg On Renal Tubular Damagesupporting
confidence: 77%
See 1 more Smart Citation
“…Accordingly, nephrotoxicity by cisplatin is characterized by renal electrolyte disturbances and by acute fall in glomerular filtration rate (GFR) [27,28]. Cisplatin teatment was found to cause diffuse tubular necrosis and desquamation and parenchyma degeneration in the cortex [29]. In the current study, turbular damage was similar to control kidney of a previous reportd study.…”
Section: Effect Of Fbg On Renal Tubular Damagesupporting
confidence: 77%
“…However, BUN and creatinine levels both WG and FBG were decreased significantly. Herein, pretreatment with WG and FBG attenuated cisplatin-induced renal dysfunction as demonstrated by normalization of BUN and creatinine level compared to cisplatin-control mice [27][28][29][30].…”
Section: Effect Of Fbg In Body and Kidney Weights And Serum Parametersmentioning
confidence: 93%
“…Moreover, edaravone reduced mitochondrial damage in homogenate made from ischemic-incubated rat brain (Watanabe et al 1994). As compared with other antioxidants, edaravone has the following advantages: (1) it has already been used in clinical practice mostly without the presence of serious side effects at the dose currently applied (Sueishi et al 2002); (2) it is lipophilic, and therefore, readily accessible to tissues (Satoh et al 2003); (3) it preferentially accumulates in the kidneys (Spitz et al 2011). This accumulation in the kidneys is desirable because it presumably confers some selectivity towards the healthy tissue and favors nephroprotection.…”
Section: Discussionmentioning
confidence: 99%
“…[30] In animal models, the S3 segment of the proximal tubule appears to be major site of renal injury. [2,18,29,31] In humans, however, damage seems to occur primarily in the distal tubule and collecting ducts. [2,4,32,33] The present study shows that repeated injection of cisplatin (5 mg/kg, i.v., three times at 21-day intervals) induced histopathological and morphometric changes in rat kidney that were reversed to a considerable extent by the chronic administration of vitamin C (8 mg/kg, i.m., daily following the first injection of cisplatin for three months).…”
Section: Discussionmentioning
confidence: 99%
“…[12] Cisplatin-induced nephrotoxicity is closely associated with an increase in lipid peroxidation in the kidney tissues. [1,5,[13][14][15][16] This agent was able to generate reactive oxygen species (ROS), such as superoxide anions and hydroxyl radicals, [3,4,17,18] and inhibit the activity of antioxidant enzymes in renal tissues. [4,5,12] Cisplatin chemotherapy induces a fall in plasma antioxidant levels, which may reflect a failure of the antioxidant defense mechanism against oxidative damage induced by commonly used antitumor drugs.…”
Section: Introductionmentioning
confidence: 99%